Founded in 2012 by Bruce Kovner, CAM Capital manages assets for Mr. Kovner and its senior employees. The firm engages in trading activities and fundamentally driven investments, with a goal of achieving long-term compounded growth. CAM Capital invests in a diverse range of industries, including biotechnology and biopharma. The firm typically invests in startups that have fewer than 4 founders and are between 11-15 years old. Notable portfolio startups include Infinity SDC, Molecular Templates, and Antios Therapeutics. CAM Capital has a higher average lead investment amount compared to other firms and had increased exits in 2017. The firm typically invests in rounds with 5-6 participants and is often financed by Third Rock Ventures, Polaris Partners, and Lux Capital.